Calmar, Inc. v. Emson Research, Inc.

838 F. Supp. 453, 1993 U.S. Dist. LEXIS 19483, 1993 WL 498932
CourtDistrict Court, C.D. California
DecidedOctober 4, 1993
DocketCV 92-4770 DT (JGx)
StatusPublished
Cited by3 cases

This text of 838 F. Supp. 453 (Calmar, Inc. v. Emson Research, Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Calmar, Inc. v. Emson Research, Inc., 838 F. Supp. 453, 1993 U.S. Dist. LEXIS 19483, 1993 WL 498932 (C.D. Cal. 1993).

Opinion

TEVRIZIAN, District Judge.

Background

This action arises out of an alleged patent infringement. The Defendant (“Emson”) alleges it has been making the accused pump sprayers (a ball type PMP pump sprayer which “burp” down the dip tube) since at least 1981.

On August 7, 1992, Plaintiff (“Calmar”) brought the instant action against Emson alleging that the pump sprayers manufactured and sold by Emson infringe Calmar’s 4,051,983 patent. Calmar, through its counsel, has since confirmed that it asserts its claims of patent infringement against these ball type sprayers whether they use a groove or a bump to “burp” down the dip tube.

On August 21, 1992, Emson brought to Calmar’s attention, U.S. Patent No. 4,144,987 (“the Kishi patent”), which was not before the Patent and Trademark Office (“PTO”) and which teaches the “down the dip tube” burping which Calmar had told the patent office was its invention. Emson also provided Calmar with the drawings of its pumps, and pointed out why its pumps did not infringe the ’983 patent.

On September 21, 1992, Emson answered the complaint, counterclaimed that the ’983 patent was invalid, and that Calmar was unfairly competing with Emson by threatening its customers with suit on the patent after having knowledge of the Kishi patent.

On October 9,1992, pursuant to Local Rule 6.2, the parties had an early meeting of counsel. During this meeting, counsel for Emson allegedly presented to Calmar’s counsel a draft Request for Reexamination, which raises a new question of patentability under 35 U.S.C. § 103. The parties allegedly agreed that counsel for Calmar would be given time to consider it.

*455 On October 26, 1992, counsel for both parties met so Calmar’s counsel could respond to the patentability issues raised in the draft Request for Reexamination, and conclude a discussion of settlement. However, Calmar allegedly refused to discuss the Request for Reexamination except to say that it did not agree that its patent was invalid or that the Emson pump sprayers did not infringe the ’983 patent.

Consequently, on November 10, 1992, Em-son filed a Request for Reexamination of the ’983 patent with the PTO. On November 20, 1992, Emson filed a Motion for Stay of Proceedings Pending Reexamination in this Court. On December 1, 1992, Calmar filed a Motion to Dismiss Emson’s Counterclaim 1 for failure to state a claim of unfair competition pursuant to Federal Rule of Civil Procedure 12(b)(6). On December 21, 1992, this Court granted Emson’s Motion for Stay of Proceedings Pending Reexamination of Cal-mar’s Patent and granted Calmar’s Motion to Dismiss Emson’s Counterclaim 1.

On August 27, 1993, Calmar filed an Ex Parte Application Under Local Rule 7.18 to Lift the Stay of Proceedings. On August 30, 1993, this Court granted the Ex Parte Application and lifted the stay. On September 9, 1993, Defendant Emson filed an Opposition to Plaintiffs Ex Parte Application to Lift the Stay of Proceedings. On September 27, 1993, this Court confirmed that the Stay of Proceedings had been lifted as of August 30, 1993.

On September 7, 1993, Calmar filed a Motion for Preliminary Injunction seeking an Order enjoining Emson from manufacturing, using, selling, advertising or offering for sale its Model 40B pump sprayer during the pendency of the instant action and for a period not to exceed October 4,1994, or from otherwise infringing Calmar’s Anderson patent during that period. This motion is currently before this Court.

Discussion

A. Standard

In considering a motion for preliminary injunction, this Court follows the procedural requirements of Federal Rule of Civil Procedure 65 and relevant ease law. Protection of the right to exclude others from utilizing the object of a patent has been provided by Congress through 35 U.S.C. § 283, which states that injunctions may be granted under the principles of equity to “prevent the violation of any rights secured by patent, on such terms as the court deems reasonable.” The granting or denial of a preliminary injunction is within the sound discretion of the court. Atari Games Corp. v. Nintendo of America, Inc., 897 F.2d 1572, 1575 (Fed.Cir.1990).

In order to obtain a preliminary injunction in patent infringement cases, the Federal Circuit has stated that the moving party must demonstrate: 1) reasonable likelihood of success on the merits; 2) lack of adequate remedy at law or other irreparable harm if preliminary relief is not granted; 3) the balance of hardships tips in the movant’s favor; and 4) the issuance of a preliminary injunction is in the public interest. See New England Braiding Co. v. A.W. Chesterton Co., 970 F.2d 878, 882 (Fed.Cir.1992); H.H. Robertson, Co. v. United Steel Deck, Inc., 820 F.2d 384, 390 (Fed.Cir.1987). Under this rule, the trial court must weigh each of the factors against the others and the magnitude of the relief requested, and no one factor, taken individually, is necessarily dispositive. Chrysler Motors Corp. v. Auto Body Panels of Ohio, Inc., 908 F.2d 951, 953 (Fed.Cir. 1990). However, the absence of an adequate showing with regard to any one factor may be sufficient, given the weight or lack of it assigned the other factors, to justify the denial of the injunction. Id. '

B. Plaintiff Calmar, Inc. Is Not Entitled To A Preliminary Injunction

1. Calmar Has Not Sufficiently Shown Absence of an Adequate Remedy at Law or Other Irreparable Harm.

Emson claims that no irreparable harm exists because Calmar has failed ■ to demonstrate any injury which could not be fully satisfied monetarily. According to Cal-mar, it has shown a harm which cannot be compensated by monetary damages because “[a]s' the Federal Circuit has stated in Atlas Powder Co. v. Ireco Chemicals, 773 F.2d 1230, 1233 (Fed.Cir.1985) and Hybritech Inc. *456 v. Abbott Laboratories, 849 F.2d 1446, 1456 (Fed.Cir.1988), patent infringement necessarily causes damage which is not compensable by money.” (Reply at 9). In this Court’s opinion, Calmar has misstated the Federal Circuit’s position.

In

Free access — add to your briefcase to read the full text and ask questions with AI

Related

3M Unitek Corp. v. Ormco Co.
96 F. Supp. 2d 1042 (C.D. California, 2000)
General Mills, Inc. v. Hunt-Wesson, Inc.
889 F. Supp. 1119 (D. Minnesota, 1995)
Calmar, Inc. v. Emson Research, Inc.
850 F. Supp. 861 (C.D. California, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
838 F. Supp. 453, 1993 U.S. Dist. LEXIS 19483, 1993 WL 498932, Counsel Stack Legal Research, https://law.counselstack.com/opinion/calmar-inc-v-emson-research-inc-cacd-1993.